Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT01084772




Registration number
NCT01084772
Ethics application status
Date submitted
19/02/2010
Date registered
10/03/2010
Date last updated
3/04/2020

Titles & IDs
Public title
Visionaire™ Versus Standard Instrumentation Safety and Efficacy in Total Knee Arthroplasty (TKA)
Scientific title
A Multicenter, Randomized, Clinical Outcome of VISIONAIRE™ Patient Matched Technology vs. Standard Surgical Instrumentation in Total Knee Arthroplasty
Secondary ID [1] 0 0
VISSTD01
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Degenerative Arthritis of Knee 0 0
Condition category
Condition code
Musculoskeletal 0 0 0 0
Osteoarthritis

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - VISIONAIRE Total Knee Arthroplasty
Other interventions - Standard Total Knee Arthroplasty

Other: VISIONAIRE Instrumentation - TKA with VISIONAIRE instrumentation

Other: Standard Instrumentation - TKA with standard instrumentation


Other interventions: VISIONAIRE Total Knee Arthroplasty
TKA will be performed with VISIONAIRE instrumentation, depending on randomization assignment.

Other interventions: Standard Total Knee Arthroplasty
TKA will be performed with standard instrumentation, depending on randomization assignment.
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Knee Society Clinical (KSS) Score at 2 Years Following Surgery - Total Score
Timepoint [1] 0 0
2 years postoperatively
Primary outcome [2] 0 0
Knee Society Clinical (KSS) Score at 2 Years Following Surgery - Clinical Evaluation Questionnaire
Timepoint [2] 0 0
2 years postoperatively
Secondary outcome [1] 0 0
Evaluation of Mechanical Alignment Assessed as Either Neutral or Varus/Valgus 3 Months Postoperatively Using a Full Leg X-ray
Timepoint [1] 0 0
3 months postoperative
Secondary outcome [2] 0 0
Knee Injury and Osteoarthritis Outcome Score (KOOS) Preoperatively and Postoperatively
Timepoint [2] 0 0
Baseline (preoperative), 3 months, 1 year, and 2 years postoperatively
Secondary outcome [3] 0 0
Serial Radiographic Evaluations to Assess Evidence of Loosening (Radiolucencies) by Measuring Lucent Zones at 1 Year Postoperatively
Timepoint [3] 0 0
1 year postoperatively
Secondary outcome [4] 0 0
Radiographic Outcomes to Assess Evidence of Loosening at 1 Year Postoperatively
Timepoint [4] 0 0
1 year postoperatively
Secondary outcome [5] 0 0
Serial Radiographic Evaluations to Assess Evidence of Loosening at 2 Years Postoperatively
Timepoint [5] 0 0
2 years postoperatively
Secondary outcome [6] 0 0
Radiographic Outcomes to Assess Evidence of Loosening at 2 Years Postoperatively
Timepoint [6] 0 0
2 years postoperatively
Secondary outcome [7] 0 0
Evaluation of Health Economic Criteria - Surgical Time Details
Timepoint [7] 0 0
During and immediately following surgery
Secondary outcome [8] 0 0
Evaluation of Health Economic Criteria - Blood Loss
Timepoint [8] 0 0
During and immediately following surgery
Secondary outcome [9] 0 0
Evaluation of Health Economic Criteria - Incision Length
Timepoint [9] 0 0
During and immediately following surgery
Secondary outcome [10] 0 0
Evaluation of Health Economic Criteria - Instrument Tray Use
Timepoint [10] 0 0
During and immediately following surgery
Secondary outcome [11] 0 0
Evaluation of Health Economic Surgical Criteria
Timepoint [11] 0 0
During and immediately following surgery

Eligibility
Key inclusion criteria
Patients must meet all of the inclusion criteria.

1. Patient diagnosed with degenerative arthritis of the knee requiring a unilateral primary TKA.
2. Patient is of legal age to consent and is skeletally mature.
3. Patient is willing to sign and date an ethics-approved consent form.
4. Patient is willing to be available for two-year follow-up postoperatively
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Patients must not meet any of the exclusion criteria.

1. Patient is known to have poor bone stock making a TKA unjustifiable.
2. Patient is immuno-suppressed.
3. Patient has physical, emotional or neurological conditions that would compromise the patient's compliance with postoperative rehabilitation and follow-up.
4. Patient is pregnant or may become pregnant during the course of the study.
5. Patient has a history of prior ipsilateral major knee surgery (e.g. arthroplasty, high tibial osteotomy, or tibial plateau fracture). Minor prior procedures such as ACL repair, meniscectomy, or arthroscopy are not excluded.
6. Patient has active, localized or systemic infection.
7. Patient is severely overweight (BMI >40).
8. Patient is a prisoner.
9. Subject has a significant MRI (magnetic resonance imaging) exclusion or contraindication.
10. Patient has had a total joint arthroplasty of the contralateral limb in the last 12 months.

Study design
Purpose of the study
Other
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Stopped early
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
21/06/2012
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/09/2015
Sample size
Target
Accrual to date
Final
134
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
Malabar Orthopaedic Clinic - Windsor
Recruitment postcode(s) [1] 0 0
3181 - Windsor
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Illinois
Country [2] 0 0
United States of America
State/province [2] 0 0
Missouri
Country [3] 0 0
United States of America
State/province [3] 0 0
Nebraska
Country [4] 0 0
United States of America
State/province [4] 0 0
North Carolina
Country [5] 0 0
United States of America
State/province [5] 0 0
Oregon

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Smith & Nephew, Inc.
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Beate Hanson, MD, PhD
Address 0 0
Smith & Nephew, Inc.
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results are available at https://clinicaltrials.gov/study/NCT01084772